Fixed drug eruption due to fluoroquinolone group of drug ciprofloxacin A case scenario and review of literature
AbstractCiprofloxacin is a broad spectrum quinolone antibiotic which is used for treating a wide variety of infections. It inhibits cell division by inhibiting DNA gyrase and topoisomerase IV enzymes. The most common adverse reactions are mild nausea, vomiting and/or abdominal discomfort in 3% to 17% of patients, mild headache and dizziness in 0.9% to 11% of patients. Rashes including photosensitivity can also occur. We report a case of 62 years old male, admitted in the hospital with the history of itching, redness and raised multiple dark skin lesion over the chest, back and oral cavity, bilateral palms and upper limbs since 2 days. On examination, multiple well- defined hyperpigmented patches with peripheral erythema seen over chest, abdomen, and back. Hyperpigmentation of lips along with the erosion of buccal mucosa and angle of mouth; erythematous plaque and exfoliation were seen in the scrotal region. Palms and scalp were spared. The patient was then treated successfully with antihistamines and steroids. The Naranjo and WHO-Uppsala monitoring center scale showed as a œprobable adverse drug reaction. œLevel 4b severity was assessed using Modified Hartwig and Seigel severity assessment scale. The steroid was tapered and the patient was discharged with advice to avoid using ciprofloxacin (fluoroquinolones) group of drugs in future.
Download data is not yet available.
Abstract : 0 | PDF : 0
How to Cite
G S, S N, A I, R MA. Fixed drug eruption due to fluoroquinolone group of drug ciprofloxacin A case scenario and review of literature. IJPR [Internet]. 28Jan.2019 [cited 19Apr.2019];9(1):e4882. Available from: https://ssjournals.com/index.php/ijpr/article/view/4882
Copyright (c) 2019 International Journal of Pharmacological Research
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
- Author must Submit Copyright form After acceptance of Article